Stockreport

Achaogen Highlights Multiple Plazomicin Presentations at IDWeek 2018

ACHAOGEN  (AKAO) 
Last achaogen earnings: 3/28 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.achaogen.com/investor-overview
PDF SOUTH SAN FRANCISCO, Calif., Oct. 03, 2018 (GLOBE NEWSWIRE) -- Achaogen, Inc. (NASDAQ: AKAO), a biopharmaceutical company discovering, developing, and commercializing [Read more]